期刊文献+

重组人PD-1IgV融合蛋白的克隆、表达、纯化及生物学活性检测 被引量:1

Cloning,expression,purification and biologic characteristics of rhPD-1IgV protein
下载PDF
导出
摘要 目的:获得具有生物学活性的重组人PD-1IgV(rh-PD-1IgV)蛋白.方法:人工合成PD-1IgV基因,并将该基因克隆入原核表达载体pQE-30中.转化宿主细胞大肠杆菌DH5α,经IPTG诱导表达重组融合rhPD-1IgV蛋白.对表达产物进行SDS-PAGE电泳和Westernblot检测分析.结果:rhPD-1IgV的Mr约为15×103,与根据其氨基酸组成计算的理论值一致.成功纯化了rhPD-1IgV蛋白,并对其进行了复性和浓缩,且复性后的蛋白可与其配体B7-H1结合,显示出良好的结合活性.结论:成功地克隆、表达和纯化了rhPD-1IgV蛋白. AIM: To obtain biologically active recombinant human PD-1IgV (rhPD-1IgV) protein. METHODS: Gene encoding for rhPD-1IgV was synthesized and cloned into the expression vector pQE-30. The expression plasmid was then trans- formed into E. coli DH5α. The expression of the fusion protein rhPD-1IgV was induced with IPTG and detected by SDS-PAGE and Western blot. The biological activity of rhPD-1IgV was identified by ELISA and flow cytometry. RESULTS: SDS-PAGE showed that the molecular weight of rhPD-1IgV was about 15 × 10^3, which was consistent with the theoretical value calculated based on the composition of amino acid. Purified rhPD-1IgV was refolded, concentrated and associated well with BT-H1. CONCLUSION: rhPD-1IgV fusion protein is successfully cloned, expressed and purified. The protein associated with B7-H1 has a strong binding activity.
出处 《第四军医大学学报》 北大核心 2006年第5期408-411,共4页 Journal of the Fourth Military Medical University
基金 教育部"长江学者和创新团队发展计划"(IRT0459)
关键词 PD-1IgV 重组融合蛋白 纯化 复性 pQE-30载体 PD-1IgV recombinant fusion protein purification refolding pQE-30 vector
  • 相关文献

参考文献10

  • 1Freeman GJ,Long AJ,Iwai Y,et al.Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation[J].J Exp Med,2000,192:1027-1034.
  • 2Wang SD,Bajorath J,Flies DB,et al.Molecular modeling and functional mapping of B7-H1 and B7-DC uncouple costimulatory function from PD-1 interaction[J].J Exp Med,2003,197 (9):1083-1091.
  • 3韩卫宁,曹云新,张赟,李琦,刘雪松,金伯泉.不同活化系统对CD4^+T细胞凋亡诱导配体表达的影响[J].第四军医大学学报,2004,25(4):343-346. 被引量:2
  • 4Iwai Y,Ishida M,Tanaka Y,et al.Involvement of PD-L1 on tumor cells in the escape from host immune system and tumor immunotherapy by PD-L1 blockade[J].PNAS,2002,99(19):12293-12297.
  • 5Ishida M,Iwai Y,Tanaka Y,et al.Differential expression of PD-L1 and PD-L2,ligands for an inhibitory receptor PD-1,in the cells of lymphohematopoietic tissues[J].Immunology,2002,84:57-62.
  • 6Osamu A,Nozomu S,Tadatoshi T,et al.Programmed death-1-programmed death-L1 interaction is essential for induction of regulatory cells by intratracheal delivery of alloantigen[J].Transplantation,2004,77(1):6-12.
  • 7Carter LL,Fouser AL,Jussif J,et al.PD-1:PD-L inhibitory pathway affects both CD^4+ and CD^8+ T cells and is overcome by IL-2[J].Eur J Immunol,2002,32(3):634-643.
  • 8Dong H,Strome S,Salomao RD,et al.Tumor-associated B7-H1 promotes T-cell apoptosis:A potential mechanism of immune evasion[J].Nat Med,2002,8(8):793-800.
  • 9Iwai Y,Terawaki S,Honjo T.PD-1 blockade inhibits hematogenous spread of poorly immunogenic tumor cells by enhanced recruitment of effector T cells[J].Int Immunol,2004,17(2):133-144.
  • 10He L,Zhang G,He Y,et al.Blockade of B7-H1 with sPD-1 improves immunity against murine hepatocarcinoma[J].Anticancer Res,2005,25(5):3309-3313.

二级参考文献6

  • 1MireSluisAR,ThorpeR.Cytokines[]..1998
  • 2Kayagaki N,Yamaguchi N,Nakayama M,et al.Involvement of TNFrelated apoptosis-inducing ligand in human CD4+T cell-mediated cytotoxicity[].J Immunol.1999
  • 3Ashkenazi A,Dixit VM: Death receptors: signaling and modulation. Science . 1998
  • 4Screaton A,Xu X.T cell life and death signaling via TNF-receptor family members[].Current Opinion in Immunology.2000
  • 5Kotelkin A,Prikhod ko EA,Cohen JI,et al.Respiratory syncytial virus infection sensitizes cells to apoptosis mediated by tumor necrosis factor-related apoptosis-inducing ligand[].Journal of Virology.2003
  • 6Gura,T,How TRAIL kills cancer cells.but not normal cells[].Science.1997

共引文献1

同被引文献10

  • 1Zhang X,Schwartz JC,Guo X.Structural and functional analysis of the costimulatory redeptor programmed death-1[J].Immunity,2004,20(5):651.
  • 2Freeman GJ,Long AJ,Iwai Y,et al.Engagment of the PD-1 immunoinhibitory recepter by a novel B7 family member leads to negative regulation of lymphocyte activiation[J].J Exp Med,2000,192:1027-1034.
  • 3Ishida Y,Agata Y,Shibahara K,et al.Induced expression of PD-1,a novel member of the immnoglobulin gene superfamily upon programmed cell death[J].EMBO J,1992,11:3887-3895.
  • 4Finger LR,Pu J,Wasserman R,et al.The PD-1 gene:complete cDNA,genomic organization,and develepmetally regulated expression in B cell progenitors[J].Gene,1997,197:177-187.
  • 5Dong H,Strome SE,Zhu G,et al.Tumor-associated B7-H1 promotes T-cell apoptosis:A potential mechanism of immune evsion[J].Nat Med,2002:8793-8800.
  • 6Iwai Y,Ishida M,Tanaka Y,et al.Involvment of PD-L1 on tumor cells in the escape from host immune system and tumor immunotherapy by PD-L1 blockade[J].Proc Natl Acad Sci USA,2002,99:12293-12297.
  • 7Fumiya H,Katsumi K,Hideto T,et al.Blockade of B7-H1 and PD-1 by monoclonal antibodies potentiates cancer thereutic immunity[J].Cancer Res,2005,65(3):1089-1096.
  • 8Xue XC,W ZL,Yan Z,et al.Production and puification of recombinant human Blys mutant from inclusion bodies[J].Protein Expr Purif,2005,42:194-199.
  • 9Barber DL,Wherry EJ,Masopust D,et al.Restoring function in exhausted CD8T cells during chronic viral infction[J].Nature,2006,439,682-687.
  • 10Day CL,Kaufmann DE,Kiepiela P,et al.PD-1expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression[J].Nature,2006,443:21.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部